Pfizer and BioNTech end COVID-19 vaccine study due to low enrollment
Pfizer and BioNTech have ended a large study for an updated COVID-19 vaccine in the United States due to low enrollment numbers to generate meaningful data. The announcement was made in a letter dated March 30 to study directors.